| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2022-02-16T03:16:57Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; YU-YUN SHAO; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-21T02:04:33Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; Hsu C.-H.; ANN-LII CHENG; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-06-10T06:10:53Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.-H.; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2018-09-10T08:05:12Z |
Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a gd-loaded peg-dendrimer-folate conjugate in a mouse xenograft tumor model
|
Chen, W.-T. and Thirumalai, D. and Shih, T.T.-F. and Chen, R.-C. and Tu, S.-Y. and Lin, C.-I. and Yang, P.-C.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2010 |
Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a gd-loaded peg-dendrimer-folate conjugate in a mouse xenograft tumor model
|
Chen W.-T.; Thirumalai D.; TIFFANY TING-FANG SHIH; Chen R.-C.; Tu S.-Y.; Lin C.-I.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:17Z |
Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a gd-loaded peg-dendrimer-folate conjugate in a mouse xenograft tumor model
|
Chen W.-T.;Thirumalai D.;Shih T.T.-F.;Chen R.-C.;Tu S.-Y.;Lin C.-I.;Pan-Chyr Yang; Chen W.-T.; Thirumalai D.; Shih T.T.-F.; Chen R.-C.; Tu S.-Y.; Lin C.-I.; PAN-CHYR YANG |
| 義守大學 |
2012-05 |
Dynamic Contrast-Enhanced Magnetic Resonance Angiography of Gd-TTDA-BOM and Gd-DTPA at 3T in a Normal Rat Model
|
Jo-Chi Jao;Yen-Ku Chen;Twei-Shiun Jaw;Yun-Ming Wang;Po-Chou Chen |
| 義守大學 |
2014-04 |
Dynamic Contrast-Enhanced Magnetic Resonance Angiography of Gd-Ttda-Bom Compared With Gd-DTPA In Normal Rat at 3T
|
Jo-Chi Jao;Yen-Ku Chen;Twei-Shiun Jaw;Yun-Ming Wang;Po-Chou Chen |
| 臺大學術典藏 |
2022-08-19T00:21:00Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Hsu C.-H.; Hu F.-C.; CHIUN HSU; Yu C.-W.; Shen Y.-C.; Hsu C.-Y. |
| 臺大學術典藏 |
2020-04-10T12:51:16Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Hu F.-C.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Chiun Hsu ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Chiun Hsu; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Yu C.-W.; Hsu C.; Hu F.-C.; CHIH-HUNG HSU; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Shen Y.-C.; Hsu C.-Y.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Chih-Hung Hsu ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Hsu C.-Y. ;Shen Y.-C. ;Chih-Wei Yu ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; CHIH-WEI YU; Hsu C.; Hu F.-C. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Chen B.-B.; Hsu C.-H.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Wei S.-Y.; Cheng A.-L.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-09-22T07:39:54Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:06Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-03-09T05:18:35Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-Y.; Ying-Chun Shen; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Wei, Shwu-Yuan; Kao, Jia-Horng; Lee, Hsuan-Shu; Shih, Tiffany Ting-Fang; 高嘉宏; 施庭芳; 許昭禹; 陳邦斌; 魏淑圓; 李宣書; 游治維 |
| 臺大學術典藏 |
2018-09-10T09:14:51Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen, B.-B. and Hsu, C.-Y. and Yu, C.-W. and Wei, S.-Y. and Kao, J.-H. and Lee, H.-S. and Shih, T.T.-F.; Chen, Bang-Bin;Hsu, Chao-Yu;Yu, Chih-Wei;Wei, Shwu-Yuan;Kao, Jia-Horng;Lee, Hsuan-Shu;Shih, Tiffany Ting-Fang; 高嘉宏 ;施庭芳 ;許昭禹 ;陳邦斌 ;魏淑圓 ;李宣書 ;游治維; TIFFANY TING-FANG SHIH; Chen, Bang-Bin; Chen, Bang-Bin; HSUAN-SHU LEE; Hsu, Chao-Yu; Hsu, Chao-Yu; Yu, Chih-Wei; CHAO-YU HSU; Yu, Chih-Wei; BANG-BIN CHEN; Wei, Shwu-Yuan; CHIH-WEI YU; Kao, Jia-Horng; Kao, Jia-Horng; Lee, Hsuan-Shu; JIA-HORNG KAO; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Shih T.T.-F.; Lee H.-S.; Kao J.-H.; Wei S.-Y.; CHIH-WEI YU; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2020-08-06T07:51:55Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee H.-S.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-09-22T07:39:54Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Shih T.T.-F.; Lee H.-S.; Kao J.-H.; Wei S.-Y.; Chen B.-B.; CHAO-YU HSU; Yu C.-W. |
| 臺大學術典藏 |
2021-09-04T06:12:04Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; JIA-HORNG KAO; Lee H.-S.; Shih T.T.-F. |
